Table 1 Patient demographics for the cohort

Age (IQR)

41 (25–57)

Gender

 Male subjects (%)

62 (80.5)

 Female subjects (%)

14 (18.2)

 N/A (%)

1 (1.3)

Admission GCS

 Eye (IQR)

1 (1–1)

 Verbal (IQR)

1 (1–1)

 Motor (IQR)

1 (1–4)

 Total (IQR)

3 (3–6)

Admission pupils

 Bilaterally reactive (%)

62 (80.5)

 Unilaterally reactive (%)

6 (7.8)

 Bilaterally unreactive (%)

8 (10.4)

 N/A (%)

1 (1.3)

Marshall CT classification

 I (%)

0 (0)

 II (%)

29 (37.7)

 III (%)

19 (24.7)

 IV (%)

6 (7.8)

 V (%)

4 (5.2)

 VI (%)

2 (2.6)

 N/A, n (%)

17 (22.1)

Follow-up GOS

 1 (%)

17 (22.1)

 2 (%)

1 (1.3)

 3 (%)

11 (14.3)

 4 (%)

18 (23.4)

 5 (%)

13 (16.9)

 N/A, n (%)

17 (22.1)

Percent time PbtO₂ less than 20 mmHg (IQR)

12.3 (4.0–28.9)

Percent time CPP less than 60 mmHg (IQR)

2.1 (0.5–4.3)

Percent time CPP greater than 70 mmHg (IQR)

86.6 (74.0–95.7)